ArticleScientific reports2024
Furosemide drug as a corrosion inhibitor for carbon steel in 1.0 M hydrochloric acid.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 10 citations in OpenAlex.
- Expired Ibrutinib as a Sustainable Corrosion Inhibitor for P110 Carbon Steel in Hydrochloric Acid: Integrated Experimental, Electrochemical, and Multiscale Computational Insights.Molecules (Basel, Switzerland) · 2026Article
- Experimental and Theoretical Insights on the Use of Expired Furosemide as Corrosion Inhibition for Cu in NaCl.Materials (Basel, Switzerland) · 2026Article
- High-efficiency corrosion protection for carbon steel in 1 M HCl using a hydrazone-based inhibitor: experimental evidence accredited with DFT and MC simulation studies.RSC advances · 2026Article
- Recycling pharmaceutical waste (vancomycin) as sustainable corrosion inhibition for API 5 L X60 carbon steel in 1 M hydrochloric acid: a combined electrochemistry and theoretical study.Scientific reports · 2026Article
- Quinazolinone derivatives as suitable mitigator for corrosion inhibition of carbon steel in hydrochloric acid environment.Scientific reports · 2026Article
- Inhibition efficacy of expired citalopram drug towards the damage of C-steel in hydrochloric acid solution.Scientific reports · 2026Article
- Article
- An overview on emerging green organic corrosion inhibitors: sustainable solution for oil and gas industrial applications.RSC advances · 2026Review
- A comprehensive experimental and theoretical perspective of novel triazole-based pyridine and quinoline derivatives for corrosion protection of carbon steel in sulfuric acid solution.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Furosemide (4-chloro-2-furan-2-ylmethylamino-5-sulfamoylbenzoic acid) was examined as an inhibitor for the corrosion of carbon steel (CS) in 1.0 M HCl. The investigation included mass loss (ML) and electrochemical techniques: potentiodynamic polarization (PP), electrochemical impedance spectroscopy (EIS), and electrochemical frequency modulation (EFM). The efficiency of inhibition rises with increasing Furosemide concentration and temperature. This compound follows the Temkin isotherm with good fit. The presence of varying quantities influences both anodic metal dissolution and cathodic hydrogen evolution. Scanning electron microscopy (SEM), atomic force microscopy (AFM), X-ray photoelectron spectroscopy (XPS), and Fourier transform infrared spectroscopy (FT-IR) were used to detect the effect of the compound on the CS surface. The molecular inhibitory effect of Furosemide was demonstrated using quantum chemical calculations, and the molecular simulation results demonstrated the adsorption on the carbon steel surface.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.